MNMaria E. Navas

Maria E. Navas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria E. Navas has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Curtis J. Donskey

    Louis Stokes Cleveland VA Medical Center

    4 shared publications
  • J Stacey Klutts

    Department of Veterans Affairs, National Policy and Laboratory Medicine Program , Washington, DC

    2 shared publications
  • Jennifer L. Cadnum

    Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio

    2 shared publications
  • Sarah N. Redmond

    Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio

    2 shared publications
  • Alexandria M. Nguyen

    Clinical Research Center, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio

    1 shared publication
  • Anas Saad

    Microbiology Laboratory, VA Northeast Ohio Health Care System

    1 shared publication

Latest Publications

  • Shortening Blood Culture Incubation Times

    by Jisha Ms Nair, Josh Bs Meyer, Nataliya Ms Kachaluba, Karen BS McIlveen, Rohini Ganjoo, Maria E. Md Navas

    The increased sensitivity of blood culture monitoring systems to detect growth has played an increasingly important role in the time to detection over the past few decades. The objective of this study was to determine the optimal incubation duration that, while maintaining sensitivity, might reduce false positive blood culture occurrences and shorten the total incubation time. We retrospectively reviewed data on positive blood cultures from the BACT/ALERT VIRTUO Microbial Detection System between January 2021 and December 2021. True positive and contaminant blood cultures were identified by reviewing the patient data from the laboratory information system. Based on the time to detection, the true positives and contaminants recovered from day 1 through day 5 were sorted, and the percentage for each day was calculated. During the study period, 977 (8.8%) out of 11,102 loaded bottles were flagged positive. On day 4, the contamination rate (2.6%) was higher than that of the true positive (0.89%). The true positives and the contaminants recovered on day 4 (P < 0.05) were significantly lower than on day 3. As no isolates were recovered on day 5, reducing the incubation time to 4 days would not affect the clinical decision making.

  • Do blood contamination reduction devices work? A single institution comparison

    by Maria E. Navas, Salman Siddiq, Laurie Bauer, Jose A. Rivera, Anita J. White, Stella Ache, Mark Osborne, Nataliya Kachaluba, Brian Klonowski, Christine Robbins, et al.

    We compare two initial specimen diversion devices evaluated over 3 months to investigate their utility in lowering blood culture contamination rates at or below 1%. Overall contamination rates during trial periods were 2.46% and 2.60% but usage was low, whereas device-specific contamination rates were 0.68% and 0.8%, respectively.


  • Open Access

    Extragenital self-collection testing for gonorrhea and chlamydia: A feasibility study for expanding STI screening in the Veterans Health Administration

    by Maria E Navas, Lewis Musoke, Puja Van Epps, Kristen Allen, Kc Coffey, Andrea Appleby-Sigler, Karla Peralta, Mark Del Pilar, Marie DuBois, Iqbal Kapadia, et al.

    Rectal and pharyngeal infections with gonorrhea and chlamydia are of concern because they are associated with higher risk of HIV acquisition. Extragenital screening in asymptomatic persons at high risk may have the potential to reduce the incidence of these sexually transmitted infections (STIs). Several testing platforms are available for the testing of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) using nucleic acid amplification tests (NAATs). Self-collected extragenital samples are currently not approved by the US Food and Drug Administration in any NAAT platform. This study compares the analytical performance of self-collected extragenital specimens to that of clinician-collected specimens. We performed a multicenter/multiplatform validation study as a National Veterans Health Administration Pathology and Laboratory Medicine quality improvement project, with 9 different participating sites. Self-collected specimens were obtained at the same time as clinician-collected specimens. Clinician-collected specimens were used as the gold standard to evaluate the sensitivity and specificity of self-collection. A total of 2324 individual tests were analyzed (501 rectal and 661 oropharyngeal). The sensitivity was 94.44% for CT and 100% for NG for rectal specimens, whereas it was 100% for CT and 97.22% for NG for oral specimens. Specificity for oral specimens was 99.85% for CT and 99.36% for NG, whereas for rectal specimens, it was 99% for CT and NG. Self-collected specimens for extragenital CT/NG testing are highly sensitive and specific, with negative predictive values of 100%. Self-collection has the potential to overcome a major barrier for STI screening by providing an accessible, convenient, and patient-centered alternative.


  • Open Access

    More harm than good? Potential benefits and unintended consequences associated with screening asymptomatic hospital admissions for severe acute respiratory syndrome coronavirus 2

    by Maria M. Torres-Teran, Maria E. Navas, Nataliya M. Kachaluba, Josh M. Meyer, Curtis J. Donskey

    To the Editor-During the coronavirus disease 2019 (COVID-19) pandemic, screening of asymptomatic patients for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the time of healthcare facility admission has often been used in an effort to reduce the risk of nosocomial transmission. 1-3 However, the Society for Healthcare Epidemiology of America recently recommended against routine use of asymptomatic screening in healthcare facilities, including admission screening. 4 Such testing is of unclear benefit when other control measures are in place and may result in unintended adverse consequences, including delays in medical care and unnecessary isolation and treatment of noninfectious patients. 4 In Veterans' Affairs (VA) hospitals, it is recommended that all new admissions be screened for SARS-CoV-2 using a polymerase chain reaction (PCR) test. At this stage of the pandemic, PCR screening can be problematic because tests often remain positive for months after COVID-19, and undiagnosed infections are not uncommon. 1,4,5 The cycle threshold (Ct) of the PCR test can be useful in assessing whether asymptomatic patients are infectious because high Ct values, which correlate with low viral burden, suggest a remote infection. 1 In previous studies, many asymptomatic patients with positive PCR tests have been deemed noninfectious based on clinical presentation, serology, and high Ct value. 1,5 Here, we conducted a retrospective study to evaluate the potential benefits and adverse consequences associated with screening asymptomatic patients being admitted to a VA hospital. The Cleveland VA Medical Center's Research and Development Committee determined that the study was a nonresearch, qualityimprovement project not requiring approval from the institutional review board. Between September 1, 2022, and January 31, 2023, we obtained the Ct values of all patients testing positive for SARS-CoV-2 on admission except those with prior COVID-19 within 90 days. The Xpert Xpress CoV-2 plus assay (Cepheid) was used for testing. Ct values were not provided in the medical record but were available to infectious diseases providers upon request. Medical records and infection control databases were reviewed to obtain information on symptoms, prior COVID-19 diagnosis, test


  • Antimicrobial Susceptibility Profile of Aerococcus urinae: Recommendations for Empirical Therapy

    by Anas Saad, Jennifer Hailes, Michael R. Jacobs, Maria E. Navas

    Background We studied the susceptibility profile of Aerococcus urinae recovered from urinary clinical samples with the aim of providing guidance in the choice of empiric antimicrobial treatment for urinary tract infection (UTI). Methods We studied stored isolates collected from UTIs of adult male and female VA patients of varying race/ethnicities from January 2019 to January 2021. Susceptibility of antimicrobials in the GPALLF3 Sensititre tray was determined. Minimum Inhibitory Concentration were interpreted based on breakpoints for Aerococcus species as outlined in the CLSI M45 standard and Streptococcus species viridans group or Enterococcus species, as outlined in the CLSI M100 standard. Results A total of 64 unique A. urinae isolates were recovered from the stored isolates. All isolates were susceptible to ampicillin, penicillin, linezolid, nitrofurantoin, and vancomycin, while 92.1% were susceptible to tetracycline, 63.6% to levofloxacin, and 44.5% to ciprofloxacin. Conclusions Our findings lead us to suggest the use of ampicillin, tetracycline, and nitrofurantoin for the empirical treatment of lower UTI caused by A. urinae.


  • A pilot randomized trial to evaluate the efficacy of oral and nasal povidone iodine in reducing the burden of severe acute respiratory syndrome coronavirus 2 RNA in patients with coronavirus disease 2019

    by Sarah N. Redmond, Daniel F. Li, Hussein Abou Ghaddara, Muhammed F. Haq, Lucas D. Jones, Alexandria M. Nguyen, Margaret Tiktin, Jennifer L. Cadnum, Maria E. Navas, Jessica Bingham, et al.


  • Bacterial urine profile and optimal urine specimen collection timing in asymptomatic chronically catheterized adults with spinal cord injuries and disorders

    by Felipe Camacho-Cordovez, M. Kristi Henzel, Laurie Bauer, Nadim G. El Chakhtoura, Kristen Leili, Federico Perez, Jessica A. Vida-Clough, Brian Klonowski, Patricia Kiefer, Curtis J. Donskey, et al.

  • Open Access

    Investigation of a cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in a hospital administration building

    by Lucas D. Jones, Ernest R. Chan, Jennifer L. Cadnum, Sarah N. Redmond, Maria E. Navas, Trina F. Zabarsky, Elizabeth C. Eckstein, Jeffrey D. Kovach, Marlin Linger, Peter A. Zimmerman, et al.

    Objective: To investigate a cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in employees working on 1 floor of a hospital administration building.Methods: Contact tracing was performed to identify potential exposures and all employees were tested for SARS-CoV-2. Whole-genome sequencing was performed to determine the relatedness of SARS-CoV-2 samples from infected personnel and from control cases in the healthcare system with coronavirus disease 2019 (COVID-19) during the same period. Carbon dioxide levels were measured during a workday to assess adequacy of ventilation; readings >800 parts per million (ppm) were considered an indication of suboptimal ventilation. To assess the potential for airborne transmission, DNA-barcoded aerosols were released, and real-time polymerase chain reaction was used to quantify particles recovered from air samples in multiple locations.Results: Between December 22, 2020, and January 8, 2021, 17 coworkers tested positive for SARS-CoV-2, including 13 symptomatic and 4 asymptomatic individuals. Of the 5 cluster SARS-CoV-2 samples sequenced, 3 were genetically related, but these employees denied higher-risk contacts with one another. None of the sequences from the cluster were genetically related to the 17 control sequences of SARS-CoV-2. Carbon dioxide levels increased during a workday but never exceeded 800 ppm. DNA-barcoded aerosol particles were dispersed from the sites of release to locations throughout the floor; 20% of air samples had >1 log10 particles.Conclusions: In a hospital administration building outbreak, sequencing of SARS-CoV-2 confirmed transmission among coworkers. Transmission occurred despite the absence of higher-risk exposures and in a setting with adequate ventilation based on monitoring of carbon dioxide levels.


  • Open Access

    Can anaerobes be acid fast? A novel, clinically relevant acid fast anaerobe

    by Maria E. Navas, Robin Jump, David H. Canaday, Maria D. Wnek, Dhruba J. SenGupta, John R. McQuiston, Melissa Bell

    Introduction: Anaerobic acid fast bacilli (AFB) have not been previously reported in clinical microbiology. This is the second case report of a novel anaerobic AFB causing disease in humans. Case presentation: An anaerobic AFB was isolated from an abdominal wall abscess in a 64–year-old Caucasian diabetic male, who underwent distal pancreatectomy and splenectomy for resection of a pancreatic neuroendocrine tumour. The isolated bacteria were gram-variable and acid-fast, consisting of small irregular rods. The 16S rRNA gene sequence analysis showed that the isolate is a novel organism described in the literature only once before. The organism was studied at the CDC (Centers for Disease Control and Prevention) by the same group that worked with the isolates from the previous report; their findings suggest that the strain belongs to the suborder Corynebacterineae. Conclusion: This is the fifth reported case of an anaerobic AFB involved in clinical disease; its microbiological features and 16S RNA sequence are identical to previously reported cases. Clinical disease with this organism seems to be associated with recent history of surgery and abscess formation in deep soft tissues. Acquisition from surgical material is uncertain but seems unlikely.